D. Max Smith

Assistant Professor

Georgetown University Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

D. Max Smith is an Assistant Professor at Georgetown University Medical Center in the United States. His research primarily focuses on pharmacogenomics and its implementation in clinical practice, including the application of DPYD genotyping and the integration of pharmacogenomic testing in oncology. He has authored several articles addressing barriers in pharmacogenomics, strategies for testing, and ensuring quality in clinical trial reporting.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (16)

Pawel Mroz

University of Minnesota

UNITED STATES

D. Max Smith

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice

A Randomized Hybrid‐Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx‐ACT) Trial

Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US

Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy

An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers

Trends in Clinical Pharmacology and Therapeutics

Pharmacogenomic Clinical Decision Support: A Scoping Review

Evidence Regarding Pharmacogenetics in Pain Management and Cancer

Ensuring Transparency and Quality of Clinical Trial Reporting in <i>Clinical Pharmacology &amp; Therapeutics</i>: Prospective Trial Registration and Compliance with Reporting Guidelines Are Required for all Clinical Trials

Pharmacogenomic Testing in Oncology: A Health System’S Approach to Identify Oncology Provider Perspectives

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy

Evaluation of a longitudinal pharmacogenomics education on pharmacist knowledge in a multicampus healthcare system

Pharmacogenetics: A precision medicine approach to combatting the opioid epidemic

Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease

Pharmacogenomic Clinical Decision Support: A Review, How-to Guide, and Future Vision.

Collaborators (16)

Pawel Mroz

Joseph Standing

Yimei Huang

James Stevenson

Sony Tuteja

Glenda Hoffecker

Philip Empey

Roseann S Gammal

Kathleen M. Giacomini

Jasmine Luzum

Julio Duarte

Daniel Hertz

Sadaf Kazi

Richard W. Peck

Nita Limdi

Henry M Dunnenberger

Make your next move.

Ensuring Transparency and Quality of Clinical Trial Reporting in <i>Clinical Pharmacology & Therapeutics</i>: Prospective Trial Registration and Compliance with Reporting Guidelines Are Required for all Clinical Trials